| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/29/2007 | EP1254162B1 Kahalalide f and related compounds |
| 08/29/2007 | EP1239814B1 Use of the residues from wine production |
| 08/29/2007 | EP1165781B1 Protease resistant flint analogs |
| 08/29/2007 | EP1140997B1 Chlamydia trachomatis antigens |
| 08/29/2007 | EP1140024B1 Particles for oral delivery of peptides and proteins |
| 08/29/2007 | EP1054963B1 Sequences of an ih ionic channel and the use thereof |
| 08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/29/2007 | EP1032269B1 Treatment of neoplasms with interferon-sensitive, clonal viruses |
| 08/29/2007 | EP1007568B1 Collagen mimics |
| 08/29/2007 | EP0998585B1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 08/29/2007 | EP0935657B1 Modified steroid hormone receptors |
| 08/29/2007 | EP0910635B1 Hematopoietic cytokine receptor |
| 08/29/2007 | EP0763059B1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
| 08/29/2007 | CN101027388A Modified human acid sphingomyelinase having increased activity, and methods for making the same |
| 08/29/2007 | CN101027320A FGFR binding peptides |
| 08/29/2007 | CN101027319A 肝素结合肽 Heparin-binding peptides |
| 08/29/2007 | CN101027317A HPV vaccine comprising peptides from host cell proteins |
| 08/29/2007 | CN101027316A Tumor targeting agents and uses thereof |
| 08/29/2007 | CN101027099A Diagnostic marker for cancer |
| 08/29/2007 | CN101027084A Mutated HIV NEF for modulating immunity |
| 08/29/2007 | CN101027082A Method of reducing serum proinsulin levels in type 2 diabetics |
| 08/29/2007 | CN101027081A Growth hormone releasing hormone enhances the immune response induced by vaccination |
| 08/29/2007 | CN101027080A Methods of protein fractionation using high performance tangential flow filtration |
| 08/29/2007 | CN101027079A 嵌合蛋白 Chimeric protein |
| 08/29/2007 | CN101027078A Composition and method for prevention or treatment of stomatits |
| 08/29/2007 | CN101027077A Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid |
| 08/29/2007 | CN101027076A Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 08/29/2007 | CN101027075A Combination therapy for the treatment of obesity |
| 08/29/2007 | CN101027074A Total enteral nutritious composition |
| 08/29/2007 | CN101027073A Natriuretic compounds, conjugates, and uses thereof |
| 08/29/2007 | CN101027065A Phospholipid compositions and methods for their preparation and use |
| 08/29/2007 | CN101027064A Medicinal composition containing diabetes therapeutic agent |
| 08/29/2007 | CN101024831A A tumor necrosis factor related ligand |
| 08/29/2007 | CN101024672A Novel ring-shape small-peptide BA and its use |
| 08/29/2007 | CN101024671A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 08/29/2007 | CN101024089A Function of E4BP4 gene inplantation course and use thereof |
| 08/29/2007 | CN101024075A Use of ulinastatin for preparing medicine for treating and protecting multi-organ function injury |
| 08/29/2007 | CN101024074A Method for treating bite injury by poisonous snake using enzyme incision technology mainly |
| 08/29/2007 | CN101024073A Use of humanbody kinino genase in preparing medicine for treating and preventing hypertension and cerebral infraction |
| 08/29/2007 | CN101024072A A composition for wound healing and use thereof |
| 08/29/2007 | CN101024071A Thymopentin injecta liquid formulation |
| 08/29/2007 | CN101023935A Method for preparing insulin capsule |
| 08/29/2007 | CN101023778A Preparation of tussor powder in rich of IGF-1 as baby pig's feed additive |
| 08/29/2007 | CN100334214C Hybrid expression of Neisseria protein |
| 08/29/2007 | CN100334112C Interfusion protein of human interleukin 15 and Fe |
| 08/29/2007 | CN100334109C GLP-1 analogues |
| 08/29/2007 | CN100334107C Ligands |
| 08/29/2007 | CN100334106C Synthesis of cyclosporin analogs |
| 08/29/2007 | CN100333790C The pharmaceutical applications for combination of drugs with interleukin-2 |
| 08/29/2007 | CN100333789C Gel gent of Chiense forest frog bactericidal peptide and its preparation process |
| 08/29/2007 | CN100333788C Tumor cell apoptosis accelerating medicine |
| 08/29/2007 | CN100333787C YG and YGG used as maintenance and improvement of immunoreaction |
| 08/28/2007 | US7262291 Clostridial toxin derivatives and methods for treating pain |
| 08/28/2007 | US7262279 A lactoferrin having an N-terminal lactoferrin variant in combination with an effective amount of an antidiabetic drug useful for decreaing blood levels of glucose and insulin thereby treating diabetes mellitus. monitoring the level of glycosylated hemoglobin (HbA1c); delayed release; hyperglycemia |
| 08/28/2007 | US7262275 Graft polymer of polyester and polypeptide; prevent cyclization |
| 08/28/2007 | US7262274 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 08/28/2007 | US7262272 Epitope from an alpha -helical surface region of a protein inserted into a coiled-coil polypeptide template; conformation-specific antibodies can be generated for use as therapeutic and diagnostic ligand. |
| 08/28/2007 | US7262271 Immunogens as well as antibodies |
| 08/28/2007 | US7262270 Ectodomain of the HIV-1IIIB envelope glycoprotein gp41 fused to a fragment of the influenza virus HA2 hemagglutinin protein. Immunization in vivo via an intraperitoneal prime followed by intranasal or intragastric boosts with gp41HA |
| 08/28/2007 | US7262268 Acylating a destryptophan compound to obtain an ornithin amino protected compound, removing the ornithine protecting group; antibiotic daptomycin stereoisomeric compounds |
| 08/28/2007 | US7262267 Polypeptide mediating cell permeability |
| 08/28/2007 | US7262224 Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof |
| 08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
| 08/28/2007 | US7262184 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
| 08/28/2007 | US7262177 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| 08/28/2007 | US7262174 Causing increased telomerase activity in cells at the wound site |
| 08/28/2007 | US7262173 Chemosensitizing with liposomes containing oligonucleotides |
| 08/28/2007 | US7262170 Pharmaceutical composition for reducing vaginal acidity and treatment of vaginitis, and the use thereof |
| 08/28/2007 | US7262168 Compositions providing for increased IGF-I solubility |
| 08/28/2007 | US7262167 Treating tumors and other conditions in a patient is provided. The method involves administering to the patient a treatment medicament. The medicament contains a first component and a second component. The first component can be a quantity of |
| 08/28/2007 | US7262166 Chemically modified novel erythropoietin stimulating protein compositions and methods |
| 08/28/2007 | US7262165 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/28/2007 | US7262164 Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 08/28/2007 | US7262163 The peptides exhibit in vitro anti-bacterial properties at concentrations that are not lethal to normal mammalian cells |
| 08/28/2007 | US7262162 Immunosuppressants; reduces tumor necrosis factor production; for treatment of sepsis/capillary leakage |
| 08/28/2007 | US7262062 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 08/28/2007 | US7262052 DNA sequence that encodes a polypeptide that is a voltage activated calcium channel alpha 2 delta -C subunit |
| 08/28/2007 | US7262050 Humanised antibodies |
| 08/28/2007 | US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/28/2007 | US7262043 Polypeptide having a specific sequence that exhibits beta -secretase activity and lacks a transmembrane domainand polynucleotides encoding them; useful for identifying agents that inhibit secretase and are thus therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease. |
| 08/28/2007 | US7262040 Incorporating into a protein an unnatural amino acid that has a saccharide moiety using an orthogonal tRNA/orthogonal aminoacyl-tRNA synthetase (O-tRNA/O-RS) pair, and contacting the saccharide moiety with a recombinant glycosyltransferase and a sugar donor to transfer a sugar to the saccharide moiety |
| 08/28/2007 | US7262026 Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
| 08/28/2007 | US7262024 Comprises nucleotide sequences coding polypeptides for diagnosis, prevention and treatment of meningitis, inflammations, bacterial and pneumonia infections |
| 08/28/2007 | US7262017 Diagnostic markers for ischemia |
| 08/28/2007 | US7262012 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 08/28/2007 | US7261901 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 08/28/2007 | US7261900 Generating imunoglobulins for prevention and treatment anthrax infection; genetic vaccines and biological warfare agents |
| 08/28/2007 | US7261897 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2007 | US7261896 Methods for preventing strokes by inducing tolerance to e-selectin |
| 08/28/2007 | US7261894 Administering an antagonistic antibody immunoreactive with IL-1 epsilon for therapy of inflammatory and/or autoimmune disease selected from the group consisting of asthma, inflammatory bowel disease, psoriasis, and combinations thereof |
| 08/28/2007 | US7261891 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 08/28/2007 | US7261889 Local anesthetic methods and kits |
| 08/28/2007 | US7261888 Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 08/28/2007 | US7261883 Vaccines containing ribavirin and methods of use thereof |
| 08/28/2007 | US7261882 Delivering antiinflammatory cytokines to nervous system using gene therapy techniques |
| 08/28/2007 | CA2294515C Eprosartan monohydrate |
| 08/28/2007 | CA2222103C Inositolglycans having insulin-like action |
| 08/28/2007 | CA2218619C Antibacterial-wound healing compositions and methods for preparing and using same |
| 08/28/2007 | CA2184727C Proteasome regulation of nf-kb activity |
| 08/28/2007 | CA2177827C Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof |